Health & Medicine

YaleNews highlights its coverage of how campus is responding to the coronavirus pandemic, and how Yale experts are taking action against the crisis.

Brito’s post-doctorate at Yale is focused on genomic epidemiology — including critical COVID research in the lab of Nathan Grubaugh.

YSPH’s Tekisha Everette is committed to understanding how U.S. policies are racialized, and to addressing their disproportionate impact on minority communities.

A new study reports that a series of biomarkers associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.

Vaccines from Pfizer-BioNTech and Moderna are being administered in the U.S. right now, with others on track for approval. So, how do they differ?

A new class of antiviral agents developed shows promise for creating COVID-19 therapeutics — particularly effective when used with the drug remdesivir.

Balancing clinical care and scholarly work is vital for physician-scientists as they progress through their careers. COVID-19 has made it harder than ever.

Yale researchers and collaborators have devised a strategy that allows them to see this previously impenetrable process unfold in a living animal.

NBC News profiles Marcella Nunez-Smith, who is trying to fix a system that is disproportionately failing disadvantaged communities.

Yale experts discuss why SARS-Cov-2 variants are emerging now – and what it will mean long-term for vaccination programs.